Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 1,150,000 | 1,046,000 | 870,000 | 818,000 | 403,300 |
Marketable Securities | 487,000 | 1,038,000 | 1,106,000 | 875,000 | 1,108,700 |
Receivables | 2,252,000 | 2,193,000 | 2,133,000 | 2,221,000 | 2,024,000 |
Inventories | 1,589,000 | 1,614,000 | 1,441,000 | 1,502,000 | 1,384,100 |
Other current assets | 990,000 | 915,000 | 941,000 | 990,000 | 1,232,300 |
TOTAL | $6,468,000 | $6,806,000 | $6,491,000 | $6,406,000 | $6,152,400 |
Non-Current Assets | |||||
PPE Net | 6,005,000 | 5,764,000 | 5,639,000 | 5,543,000 | 5,463,400 |
Investments And Advances | 1,163,000 | 1,198,000 | 606,000 | 527,000 | 544,900 |
Other Non-Current Assets | 3,186,000 | 2,934,000 | 2,951,000 | 2,720,000 | 2,559,400 |
TOTAL | $10,354,000 | $9,896,000 | $9,196,000 | $8,790,000 | $8,567,700 |
Total Assets | $14,667,000 | $14,616,000 | $13,619,000 | $13,174,000 | $12,729,300 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 913,000 | 750,000 | 652,000 | 602,000 | 715,300 |
Accrued Expenses | 436,000 | 437,000 | 417,000 | 389,000 | 421,300 |
Other current liabilities | 1,164,000 | 1,034,000 | 1,508,000 | 1,380,000 | 1,192,800 |
TOTAL | $5,640,000 | $6,199,000 | $5,848,000 | $5,482,000 | $5,187,200 |
Non-Current Liabilities | |||||
Long Term Debt | 687,000 | 553,000 | 583,000 | 584,000 | 833,000 |
Other Non-Current Liabilities | 1,133,000 | 1,135,000 | 1,047,000 | 1,034,000 | 1,036,400 |
TOTAL | $2,073,000 | $1,851,000 | $1,787,000 | $1,804,000 | $2,035,500 |
Total Liabilities | $7,713,000 | $8,050,000 | $7,635,000 | $7,286,000 | $7,222,700 |
Shareholders' Equity | |||||
Common Shares | 34,000 | 34,000 | 34,000 | 34,000 | 34,300 |
Retained earnings | 8,017,000 | 7,707,000 | 7,194,000 | 7,184,000 | 6,858,900 |
Other shareholders' equity | -1,343,000 | -1,271,000 | -1,186,000 | -1,106,000 | -1,006,800 |
TOTAL | $6,954,000 | $6,566,000 | $5,984,000 | $5,888,000 | $5,506,600 |
Total Liabilities And Equity | $14,667,000 | $14,616,000 | $13,619,000 | $13,174,000 | $12,729,300 |